Immunotherapy plus chemo and radiation for nasal cancer
Treatments studied
Part of Cancer clinical trials.
This Phase 2 study tests a treatment plan that combines immunotherapy with chemotherapy and chemoradiation for advanced squamous cell cancer in the nasal cavity or sinuses. It aims to improve cancer control in people who are newly diagnosed and have not had prior treatment for this cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 18 or older and newly diagnosed with squamous cell cancer of the nasal cavity or sinuses (stage II through IVb) that hasn’t been treated before
- Have measurable cancer that can be tracked on scans (measurable disease)
- Have a usable tissue sample from the tumor (archived or a fresh biopsy), and it should be from an area that has not been radiated before
- Your body’s health tests must be “strong enough,” including recent blood work within 14 days before starting
- Your cancer-related activity level should be mild (ECOG 0–1)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of an immunotherapy drug (toripalimab) plus chemotherapy before surgery for sinus cancer that has not spread. The goal is to see if this treatment shrinks the tumor so surgery can be more effective.
This trial tests a combination of an immunotherapy drug (toripalimab) and two chemotherapy drugs (cisplatin and docetaxel) as a first treatment before surgery or radiation for advanced head and neck cancers. It may help shrink tumors that can't be easily treated with standard therapy.
This trial tests pembrolizumab (an immune therapy) for locally advanced sinonasal cancer that can still be cured with local treatments. It aims to improve outcomes by helping your immune system better fight the tumor.
This trial tests whether adding chemotherapy to a combination of immunotherapy and radiation is more effective than immunotherapy and radiation alone for advanced nasopharyngeal cancer. It is for people whose cancer has not spread to distant organs.
This trial tests whether combining chemotherapy with two immunotherapy drugs (PD-1 inhibitors) before surgery can improve outcomes for patients with advanced sinonasal carcinoma. It aims to shrink the tumor before removal.
This trial tests whether adding the immunotherapy drug cemiplimab to standard chemotherapy before surgery helps treat sinonasal squamous cell carcinoma. The goal is to see if this combination reduces tumors more effectively than chemotherapy alone.
Hear when a new Squamous Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.